UKRI Engineering Biology Missions award millions in funding to Imperial projects
UKRI has awarded millions in funding for Imperial projects, through their new Engineering Biology Missions.
1
Morphine treatment and cheating sparrows: News from Imperial
Here’s a batch of fresh news and announcements from across Imperial.
UK approves world-first gene-editing treatment for blood disorders
The UK has become the first country in the world to approve a gene therapy as a potential cure for two inherited blood disorders.
Bendy X-rays and DMT infusions: News from Imperial
Here’s a batch of fresh news and announcements from across Imperial.
River sampling study shows impact of COVID-19 pandemic on London’s waterways
The most detailed study of a city’s waterways anywhere in the world has revealed how chemical pollutants in London’s rivers changed over the pandemic.
£1.5m ‘Quest for Cures’ grant to tackle aggressive brain tumours
An Imperial team engineering new techniques in cancer immunotherapy has been awarded £1.5m over five years.
New centre established to help develop drug delivery and vaccine technologies
The Intracellular Drug Delivery Centre aims to develop new drug delivery technologies and support promising RNA vaccines and therapeutics.
Imperial addiction researcher appointed to national role to tackle drug harms
Anne Lingford-Hughes has been appointed to a national role aimed at tackling addiction and improving treatment outcomes.
New partnership will use molecular glues to tackle ‘undruggable’ disease targets
Researchers at Imperial, the Francis Crick Institute and AstraZeneca will advance the discovery of new ‘molecular glues’ to treat a range of diseases.
Advanced brain imaging study hints at how DMT alters perception of reality
Scientists have gleaned new insights into how psychedelics alter conscious experience via their action on brain activity.
